Start here if you're new
what it is
Movano sells a medical ring and health data tools for a company that made $1M last year.
how it gets paid
Last year Movano made $1M in revenue. Evie Ring device sales was the main engine at $0.70M, or 70% of sales.
what just happened
Revenue was $389K, and EPS was -$15.91.
At a glance
C balance sheet — red flag territory — real financial stress
-$39.40 fy2024 eps est
n/m fy2026 rev — $2B print looked like a bad feed vs $1M base
n/a operating margin — deep operating loss
1.2 beta
xvary composite: 10/100 — weak
What they do
Movano sells a medical ring and health data tools for a company that made $1M last year.
Your moat is thin. Movano has 32 employees and $1M of annual revenue, so every sale matters. The merger says the market agrees: Movano holders get 3.8% of the combined company, while Corvex holders get 96.2%.
How they make money
$1M
annual revenue
Evie Ring device sales
$0.70M
Movano Health app
$0.10M
Purpose-driven healthcare solutions
$0.05M
Clinical and data services
$0.12M
Other revenue
$0.03M
The products that matter
health-tech development
Legacy Movano Platform
$1M trailing revenue
It generated the company's entire $1M in trailing revenue. That's enough to prove the company exists, not enough to support the current public story on its own.
legacy business
ai cloud infrastructure
Corvex Merger
expected close Q1 2026
This pending transaction is the whole thesis. If it closes, MOVE becomes a different business. If it does not, you are left with the $1M legacy platform and the same cash burn problem.
binary catalyst
Key numbers
$1M
annual revenue
This is the whole business base. A $15M market cap against $1M of sales is a 15x multiple.
-$39.40
fy2024 eps
You lost $39.40 per share in 2024. That is not a rounding error.
32
employees
A 32-person team is trying to build a healthcare hardware business. That is lean, and fragile.
96.2%
Corvex stake
The merger leaves Movano holders with 3.8%. You are not getting control.
Financial health
C
strength
- balance sheet grade C — very weak — significant financial distress
- risk rank 5 — safer than 5% of stocks
- price stability 5 / 100
C — below average. watch for debt servicing and cash burn.
Total return vs. market
Return history isn't available for MOVE right now.
source: institutional data · return history unavailable
What just happened
missed estimates
Revenue was $389K, and EPS was -$15.91.
Revenue rose 386% Vs. last year, but the base stayed tiny. Full-year revenue was $1M, and 2024 EPS was -$39.40.
$389K
revenue (Q)
-$15.91
eps (Q)
+386%
rev. growth (Q vs. prior year)
base size
The $389K quarter matters because a company with $1M of annual revenue cannot hide a bad quarter.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
The top risk is the Corvex merger failing or slipping past Q1 2026. For MOVE, that is not one risk among many. It is the thing the rest of the page is orbiting.
med
Merger failure
The company is expected to merge with Corvex in Q1 2026. If the deal breaks, investors are pushed back to the legacy reality: $1M in revenue and a n/a operating margin.
That would remove the entire forward narrative in one move and force a valuation reset around the stand-alone business.
med
Dilution and selling pressure
The 110M-share resale facility is more than seven times the current public float, and 545,456 shares were already registered for sale in February 2026.
Even if the deal closes, heavy share supply can pressure your returns long before the combined company proves anything operationally.
med
Runway compression
Cash on hand is $21.3M. Operating cash outflow is $22.5M over the last 12 months.
If burn stays near this level and the transaction is delayed, financing stops being optional and starts being urgent.
med
Disclosure gap
Today you can analyze legacy Movano's weak economics. The post-merger case depends on Corvex, which means your thesis rests on a business not yet reporting here as the combined public company.
That makes underwriting the story harder. You are betting on a transition before you have a long public track record for the combined operation.
The combined risk picture is easy to say and hard to own: a $15M stock, $21.3M of cash, $22.5M of annual burn, and a 110M-share overhang all have to coexist with a single deal close in Q1 2026.
source: institutional data · regulatory filings · risk analysis
Pay attention to
deadline
Q1 2026 merger close
This is the clock the whole stock is trading against. If the date slips, your valuation framework has to change with it.
runway
cash burn versus $21.3M cash
The next report should tell you whether the $22.5M operating cash outflow is stabilizing or still chewing through runway at the same pace.
share supply
resale facility activity
A 110M-share facility can dominate trading in a stock this small. New registrations matter because supply matters.
report date
expected March 19, 2026 filing
Treat it as a solvency and timeline update first, and a normal earnings release second.
Analyst rankings
near-term earnings view
-$6.70 eps expected
Consensus is still modeling another heavy loss. In human-speak, analysts are not expecting the stand-alone business to suddenly become healthy.
revenue narrative
pro forma / merger-only
Any multi-billion FY2026 revenue line is post-Corvex math, not a straight-line from today’s $1M legacy base. Treat published $2B ticks as scenario noise until the deal closes.
coverage depth
thin
There is no broad ranking set published on this page, which fits the setup. This is a small, event-driven stock where filings matter more than a crowded analyst consensus.
source: institutional data
Institutional activity
institutional ownership data for MOVE is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$13
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive